Connor, Clark & Lunn Investment Management (CC&L)’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-8,158
| Closed | -$342K | – | 1418 |
|
2024
Q1 | $342K | Sell |
8,158
-20,380
| -71% | -$855K | ﹤0.01% | 1223 |
|
2023
Q4 | $1.13M | Buy |
28,538
+10,383
| +57% | +$412K | 0.01% | 828 |
|
2023
Q3 | $500K | Buy |
+18,155
| New | +$500K | ﹤0.01% | 1017 |
|
2023
Q2 | – | Sell |
-42,636
| Closed | -$1.53M | – | 1335 |
|
2023
Q1 | $1.53M | Sell |
42,636
-15,274
| -26% | -$550K | 0.01% | 616 |
|
2022
Q4 | $2.58M | Sell |
57,910
-22,740
| -28% | -$1.01M | 0.01% | 483 |
|
2022
Q3 | $2.27M | Buy |
+80,650
| New | +$2.27M | 0.01% | 472 |
|
2021
Q4 | – | Sell |
-12,117
| Closed | -$654K | – | 1093 |
|
2021
Q3 | $654K | Sell |
12,117
-2,416
| -17% | -$130K | ﹤0.01% | 719 |
|
2021
Q2 | $486K | Buy |
+14,533
| New | +$486K | ﹤0.01% | 795 |
|
2021
Q1 | – | Sell |
-37,346
| Closed | -$654K | – | 994 |
|
2020
Q4 | $654K | Sell |
37,346
-14,233
| -28% | -$249K | ﹤0.01% | 690 |
|
2020
Q3 | $765K | Buy |
+51,579
| New | +$765K | 0.01% | 672 |
|
2018
Q4 | – | Sell |
-51,337
| Closed | -$347K | – | 950 |
|
2018
Q3 | $347K | Sell |
51,337
-8,675
| -14% | -$58.6K | ﹤0.01% | 764 |
|
2018
Q2 | $453K | Buy |
60,012
+13,009
| +28% | +$98.2K | ﹤0.01% | 792 |
|
2018
Q1 | $1.64M | Buy |
47,003
+11,274
| +32% | +$394K | 0.01% | 412 |
|
2017
Q4 | $1.52M | Sell |
35,729
-79
| -0.2% | -$3.37K | 0.01% | 465 |
|
2017
Q3 | $1.54M | Buy |
35,808
+1,225
| +4% | +$52.5K | 0.01% | 462 |
|
2017
Q2 | $1.28M | Buy |
34,583
+29,010
| +521% | +$1.07M | 0.01% | 460 |
|
2017
Q1 | $302K | Buy |
+5,573
| New | +$302K | ﹤0.01% | 729 |
|
2015
Q2 | – | Sell |
-1,380
| Closed | -$577K | – | 621 |
|
2015
Q1 | $577K | Sell |
1,380
-293
| -18% | -$123K | ﹤0.01% | 376 |
|
2014
Q4 | $458K | Buy |
+1,673
| New | +$458K | ﹤0.01% | 400 |
|
2014
Q2 | – | Sell |
-7,840
| Closed | -$2.29M | – | 542 |
|
2014
Q1 | $2.29M | Buy |
7,840
+1,653
| +27% | +$484K | 0.02% | 260 |
|
2013
Q4 | $2.39M | Sell |
6,187
-73
| -1% | -$28.2K | 0.02% | 238 |
|
2013
Q3 | $3.42M | Buy |
6,260
+2,053
| +49% | +$1.12M | 0.03% | 143 |
|
2013
Q2 | $1.04M | Buy |
+4,207
| New | +$1.04M | 0.01% | 259 |
|